Literature DB >> 29466740

TALEN-Induced Double-Strand Break Repair of CTG Trinucleotide Repeats.

Valentine Mosbach1, Lucie Poggi1, David Viterbo2, Marine Charpentier3, Guy-Franck Richard4.   

Abstract

Trinucleotide repeat expansions involving CTG/CAG triplets are responsible for several neurodegenerative disorders, including myotonic dystrophy and Huntington's disease. Because expansions trigger the disease, contracting repeat length could be a possible approach to gene therapy for these disorders. Here, we show that a TALEN-induced double-strand break was very efficient at contracting expanded CTG repeats in yeast. We show that RAD51, POL32, and DNL4 are dispensable for double-strand break repair within CTG repeats, the only required genes being RAD50, SAE2, and RAD52. Resection was totally abolished in the absence of RAD50 on both sides of the break, whereas it was reduced in a sae2Δ mutant on the side of the break containing the longest repeat tract, suggesting that secondary structures at double-strand break ends must be removed by the Mre11-Rad50 complex and Sae2. Following the TALEN double-strand break, single-strand annealing occurred between both sides of the repeat tract, leading to repeat contraction.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TALEN; double-strand break; myotonic dystrophy; single-strand annealing; trinucleotide repeats

Mesh:

Substances:

Year:  2018        PMID: 29466740     DOI: 10.1016/j.celrep.2018.01.083

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  14 in total

Review 1.  The role of fork stalling and DNA structures in causing chromosome fragility.

Authors:  Simran Kaushal; Catherine H Freudenreich
Journal:  Genes Chromosomes Cancer       Date:  2019-01-29       Impact factor: 5.006

Review 2.  Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models.

Authors:  Vanessa C Wheeler; Vincent Dion
Journal:  J Huntingtons Dis       Date:  2021

Review 3.  Homologous recombination within repetitive DNA.

Authors:  Erica J Polleys; Catherine H Freudenreich
Journal:  Curr Opin Genet Dev       Date:  2021-08-28       Impact factor: 5.578

Review 4.  Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Authors:  Seren Marsh; Britt Hanson; Matthew J A Wood; Miguel A Varela; Thomas C Roberts
Journal:  Mol Ther       Date:  2020-10-14       Impact factor: 11.454

Review 5.  Structure-forming repeats and their impact on genome stability.

Authors:  Rebecca E Brown; Catherine H Freudenreich
Journal:  Curr Opin Genet Dev       Date:  2020-12-03       Impact factor: 5.578

6.  Mrc1 and Tof1 prevent fragility and instability at long CAG repeats by their fork stabilizing function.

Authors:  Lionel Gellon; Simran Kaushal; Jorge Cebrián; Mayurika Lahiri; Sergei M Mirkin; Catherine H Freudenreich
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 16.971

7.  Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.

Authors:  Mirella Lo Scrudato; Karine Poulard; Célia Sourd; Stéphanie Tomé; Arnaud F Klein; Guillaume Corre; Aline Huguet; Denis Furling; Geneviève Gourdon; Ana Buj-Bello
Journal:  Mol Ther       Date:  2019-06-05       Impact factor: 11.454

8.  A fast, sensitive and cost-effective method for nucleic acid detection using non-radioactive probes.

Authors:  David Viterbo; Astrid Marchal; Valentine Mosbach; Lucie Poggi; Wilhelm Vaysse-Zinkhöfer; Guy-Franck Richard
Journal:  Biol Methods Protoc       Date:  2018-06-25

Review 9.  Studying DNA Double-Strand Break Repair: An Ever-Growing Toolbox.

Authors:  Alexandra C Vítor; Pablo Huertas; Gaëlle Legube; Sérgio F de Almeida
Journal:  Front Mol Biosci       Date:  2020-02-21

10.  Correction of the aprt Gene Using Repair-Polypurine Reverse Hoogsteen Hairpins in Mammalian Cells.

Authors:  Alex J Félix; Carlos J Ciudad; Véronique Noé
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-24       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.